Please provide your email address to receive an email when new articles are posted on . Single maintenance and reliever therapy (SMART) had a lower total annual asthma management cost vs. traditional ...

The FDA approved Breztri Aerosphere, a single-inhaler triple therapy, as a maintenance treatment for patients aged at least ...

CHICAGO -- A fixed-dose inhaler combining an inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting beta agonist (ICS/LAMA/LABA) improved lung function and reduced exacerbations in ...

Inhalers In patients with COPD, treatment with single-inhaler fluticasone furoate/umeclidinium/vilanterol resulted in more health status improvements and greater lung ...

The National Institute for Health and Care Excellence (NICE) has issued 'landmark' guidelines for any asthma sufferers still ...

MADRID — For patients whose asthma is not well controlled, the addition of a long-acting muscarinic antagonist to the two-drug combination of an inhaled corticosteroid and a long-acting beta2 agonist ...

New triple therapy: The FDA approved AstraZeneca’s Breztri Aerosphere for asthma patients 12 and older, offering a single inhaler combining ICS/LABA with a LAMA for maintenance treatment. Device ...

Among patients with chronic obstructive pulmonary disease who received prior treatment with multiple-inhaler triple therapy, single-inhaler triple therapy was effective in improving health status and ...

The IMPACT and ETHOS trials showed that single-inhaler triple therapy significantly reduce the rate of COPD exacerbation and mortality compared with dual bronchodilators. Findings are from an ...

Health chiefs have issued a call to anyone using the medication to treat asthma attacks ...

SPL84 is administered directly into the lungs where it is taken up by the cells and is expected to drive the production of fully functional CFTR proteins. The Food and Drug Administration (FDA) has ...